ebook Munafa Stock Market Course + Intraday & FNO calls  

       

VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

Venus Remedies Limited Complete list of announcements declared & dividend announcements by Venus Remedies Limited VENUSREM_BE

Venus Remedies Limited VENUSREM_BE listed on NSE and deals in

Announcements and dividends declared by Venus Remedies Limited VENUSREM_BE

Venus Remedies gets market authorisations for cancer drugs from 4 nations
Pharma major Venus Remedies on Monday said it has received market authorisations for its key cancer drugs from Philippines, Paraguay, Georgia and Moldova. With this, the company has secured 506 marketing approvals for its oncology products across 76 countr
Announcement as on 31 July 2023

Venus Remedies stops trading as sharp rally triggers enhanced surveillance measures by Sebi
SEBI recently introduced ESM framework for micro and small companies with market cap below 500 crore, leading to trading restrictions based on price variations.
Announcement as on 13 July 2023

Venus Remedies jumps 3% on nod to operate in 4 foreign markets
The company has secured 503 marketing approvals for its oncology products across 75 countries.
Announcement as on 05 July 2023

Venus Remedies hits 5% upper circuit on drug approval in Spain
The company got its approval through its German subsidiary for 500 mg, 1 g and 2 g injections of meropenem, which is used in treating skin and abdominal infections
Announcement as on 22 June 2023

Venus Remedies gets marketing authorization from Saudi Arabia for chemotherapy drug Docetaxel
The development comes three months after the company received good manufacturing practices (GMP) certification from the Saudi Food and Drug Authority (SFDA) for all its production facilities at its unit in Baddi, Himachal Pradesh.
Announcement as on 01 June 2023

Announcements by Venus Remedies Limited first page | Next page | Prev page |

VENUSREM_BE Venus Remedies Limited current price & indicator signals

Moving Averages for Venus Remedies Limited

  • 5Day Average: 734.55
  • 12Day Average: 735.81
  • 20Day Average: 746.73
  • 50Day Average: 687.97
  • 100Day Average: 583.52
  • 150Day Average: 476.29
  • 200Day Average: 398.63

VENUSREM_BE Indicators & signals

Indicator MACD (12,26,9)

739.26, 733.63, 13.78
Indicator MACD is in positive zone

Indicator ADX (14)

3.7, 19.4, 20.89
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of VENUSREM_BE Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
23 Fri Jan 2026 713.10 706.60 to 754.00 -4.12% 0.54 times
22 Thu Jan 2026 743.75 719.00 to 754.00 2% 0.3 times
21 Wed Jan 2026 729.15 690.00 to 740.00 0.4% 0.65 times
20 Tue Jan 2026 726.25 722.50 to 767.00 -4.5% 0.93 times
19 Mon Jan 2026 760.50 737.00 to 780.70 -0.16% 0.42 times
16 Fri Jan 2026 761.75 741.20 to 790.00 -1% 1.28 times
14 Wed Jan 2026 769.45 745.10 to 780.70 3.48% 1.53 times
13 Tue Jan 2026 743.55 702.55 to 743.55 5% 0.79 times
12 Mon Jan 2026 708.15 685.55 to 734.70 -1.86% 1.17 times
09 Fri Jan 2026 721.60 685.00 to 729.95 1.9% 0.8 times
08 Thu Jan 2026 708.15 707.10 to 742.00 -4.86% 2.13 times
07 Wed Jan 2026 744.30 730.00 to 765.40 -0.17% 0.53 times

Videos related to: VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

VENUSREM_BE announcements Venus Remedies Limited announcements and dividends declared NSE

 

Back to top